Trump and AstraZeneca Reach Deal to Lower Drug Prices for Medicaid Patients

AstraZeneca has reached a significant agreement with President Trump to lower drug prices for Medicaid patients, allowing access to medications at rates comparable to the lowest prices in other developed countries. This initiative is part of the administration's broader efforts to make healthcare more affordable for Americans, potentially benefiting millions who struggle with high medication costs. The deal reflects a proactive approach to addressing healthcare and economic challenges in the pharmaceutical industry.